Top

Published in:

01-03-2009 | Research Paper

The CXCR4/CXCL12 axis in endometrial cancer

Authors: Stefania Gelmini, Monica Mangoni, Francesca Castiglione, Cristina Beltrami, Annalisa Pieralli, Karin Louise Andersson, Massimiliano Fambrini, Gian Luigi Taddei, Mario Serio, Claudio Orlando

Published in: Clinical & Experimental Metastasis | Issue 3/2009

Abstract

Chemokines and their receptors seem to act as important regulators of the metastatic cascade. CXCL12 and its receptor CXCR4 were shown to be involved in human cancer progression. There is increasing evidences suggesting that the expression of CXCR4 in human cancers is correlated with poor patient prognosis and that CXCR4 neutralization can prevent metastases in vivo. Here we tested the role of the CXCR4/CXCL12 axis in a neoplasia with a reduced risk of metastatic progression, such as human endometrial cancer. CXCR4 and CXCL12 mRNA expression was measured in 41 endometrial cancers and in corresponding not affected tissues. The expression of CXCR4 was predominant in endometrial cancer (P = 0.035) whereas CXCL12 was overexpressed in normal mucosae (P = 0.002). CXCR4 expression (P = 0.035), but not CXCL12, was significantly related to cancer differentiation. Endometrial cancer cells (HEC1A) were able to generate diffuse metastases in peritoneum, lung and liver of CD-1 nude mice, but the simultaneous treatment with a neutralizing anti-CXCR4 monoclonal antibody dramatically reduced the number and the size of metastases in the animals. In conclusion, our data seem to indicate that the CXCR4-CXCL12 axis can play a role in the progression of endometrial carcinoma and that specific therapies with antagonists of chemokines receptors could be of help in the treatment of metastatic patients.

Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. Cancer J Clin 58:71–96. doi:10.3322/CA.2007.0010 CrossRef

Williams JW, Hirschowitz L (2006) Assessment of uterine wall thickness and position of the vascular plexus in the deep myometrium:implications for the measurement of depth of myometrial invasion of endometrial carcinomas. Int J Gynecol Pathol 25:59–64. doi:10.1097/01.pgp.0000177123.78932.1d PubMedCrossRef

Tsukamoto H, Shibata K, Kajiama H et al (2007) Uterine smoth muscle cells increase invasive ability of endometrial carcinoma cells through tumor-stromal interaction. Clin Exp Metastasis 24:423–429. doi:10.1007/s10585-007-9079-5 PubMedCrossRef

Southcott BM (2001) Carcinoma of the endometrium. Drugs 61:1395–1405. doi:10.2165/00003495-200161100-00003 PubMedCrossRef

Ben-Baruch A (2008) A Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345–356. doi:10.1007/s10585-007-9097-3 PubMedCrossRef

Strieter RM, Burdick MD, Mestas J et al (2006) Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42:768–778. doi:10.1016/j.ejca.2006.01.006 PubMedCrossRef

Schier AF (2003) Chemokine signaling: rules of attraction. Curr Biol 13:R192–R194. doi:10.1016/S0960-9822(03)00122-2 PubMedCrossRef

Broxmeyer HE, Cooper S, Kohli L et al (2003) Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol (Baltimore, MD: 1950) 170:421–429

Horuk R (2001) Chemokine receptors. Cytokine Growth Factor Rev 12:313–335. doi:10.1016/S1359-6101(01)00014-4 PubMedCrossRef

10.

Wendt MK, Johanesen PA, Kang-Decker N et al (2006) Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 25:4986–4997. doi:10.1038/sj.onc.1209505 PubMedCrossRef

11.

Kakinuma T, Hwang ST (2006) Chemokines, chemokines receptors, and cancer metastasis. J Leukoc Biol 79:639–650. doi:10.1189/jlb.1105633 PubMedCrossRef

12.

Wang J, Shiozawa Y, Wang J et al (2008) The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 283:4283–4294. doi:10.1074/jbc.M707465200 PubMedCrossRef

13.

Koizumi K, Hojo S, Akashi T et al (2007) Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Science 98:1652–1658. doi:10.1111/j.1349-7006.2007.00606.x PubMedCrossRef

14.

Tanaka K, Bai Z, Srinoulprasert Y et al (2005) Chemokines in tumor progression and metastasis. Cancer Science 96:317–322. doi:10.1111/j.1349-7006.2005.00059.x PubMedCrossRef

15.

Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56. doi:10.1038/35065016 PubMedCrossRef

16.

Koizumi K, Kozawa Y, Ohashi Y et al (2007) CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncology Rep 17:1511–1516

17.

Kryczek I, Wei S, Keller E et al (2007) Stroma-derived factor (SDF1/CXCL12) and human pathogenesis. Am J Physiol Cell Physiol 292:C987–C995PubMedCrossRef

18.

Kim J, Takeuchi H, Lam ST et al (2005) Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23:2744–2753. doi:10.1200/JCO.2005.07.078 PubMedCrossRef

19.

Scala S, Ottaiano A, Ascierto PA et al (2005) Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 11:1835–1841. doi:10.1158/1078-0432.CCR-04-1887 PubMedCrossRef

20.

Li YM, Pan Y, Wei Y et al (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6:429–430. doi:10.1016/j.ccr.2004.09.027 CrossRef

21.

Rombouts EJ, Pavic B, Löwenberg B et al (2004) Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood 104:550–557. doi:10.1182/blood-2004-02-0566 PubMedCrossRef

22.

Spano JP, Andre F, Morat L et al (2004) Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15:613–617. doi:10.1093/annonc/mdh136 PubMedCrossRef

23.

Sun YX, Fang M, Wang J et al (2007) Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 67:61–73. doi:10.1002/pros.20500 PubMedCrossRef

24.

Kajiyama H, Shibata K, Terauchi M et al (2008) Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 122:91–99. doi:10.1002/ijc.23083 PubMedCrossRef

25.

De Falco V, Guarino V, Avilla E et al (2007) Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res 67:11821–11829. doi:10.1158/0008-5472.CAN-07-0899 PubMedCrossRef

26.

Brian XW, Yang SX, Chen JH et al (2007) Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 61:570–578CrossRef

27.

Gockel I, Schimanski CC, Heinrich C et al (2006) Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer 6:290. doi:10.1186/1471-2407-6-290 PubMedCrossRef

28.

Kodama J, Hasengaowa, Kusumoto T et al (2007) Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol 18:70–76. doi:10.1093/annonc/mdl342 PubMedCrossRef

29.

Oda Y, Yamamoto H, Tamiya S et al (2006) CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 19:738–745. doi:10.1038/modpathol.3800587 PubMedCrossRef

30.

Shen W, Bendall LJ, Gottlieb DJ et al (2001) The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Exp Hematol 29:1439–1447. doi:10.1016/S0301-472X(01)00741-X PubMedCrossRef

31.

Tavor S, Petit I, Porozov S et al (2004) CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 64:2817–2824. doi:10.1158/0008-5472.CAN-03-3693 PubMedCrossRef

32.

Cardones AR, Murakami T, Hwang ST et al (2003) CXCR4 enhances adhesion of B16 to endothelial cells tumor cells in vitro and in vivo via beta(1) integrin. Cancer Res 63:6751–6757PubMed

33.

Zeelemberg IS, Ruuls-Van Stalle S et al (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:3833–3839

34.

Sun YX, Schmeider A, Yung Y et al (2005) Skeletal localisation and neutralisation of SDF1 (CXCL12/CXCR4) axis blocks prostate cancer metastasis and growth in osseus sites in vivo. J Bone Miner Res 20:318–329. doi:10.1359/JBMR.041109 PubMedCrossRef

35.

Burns JM, Summers BC, Wang Y et al (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. JEM 203:2201–2213. doi:10.1084/jem.20052144 CrossRef

36.

Kodama J, Hasengaowa, Seki N et al (2007) Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer. Eur J Gynaecol Oncol 28:370–375PubMed

37.

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using Real-Time Quantitative PCR and the 2^−ΔΔCt method. Methods (San Diego, CA) 25:402–408. doi:10.1006/meth.2001.1262

38.

Zlotnik A (2006) Chemokines and cancer. Int J Cancer 119:2026–2029. doi:10.1002/ijc.22024 PubMedCrossRef

39.

Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171–179. doi:10.1016/j.semcancer.2003.10.003 PubMedCrossRef

40.

Fernandis AZ, Prasad A, Band H et al (2004) Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23:157–167. doi:10.1038/sj.onc.1206910 PubMedCrossRef

41.

Janowska-Wieczorek A, Marquez LA, Dobrowsky A et al (2000) Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 28:1274–1285. doi:10.1016/S0301-472X(00)00532-4 PubMedCrossRef

42.

Samara GJ, Lawrence DM, Chiarelli CJ et al (2004) CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 214:231–241. doi:10.1016/j.canlet.2004.04.035 PubMedCrossRef

43.

Murphy PM (2001) Chemokines and molecular basis of cancer metastasis. N Engl J Med 345:833–835. doi:10.1056/NEJM200109133451113 PubMedCrossRef

44.

Allinen M, Beroukhim R, Cai L et al (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6:17–32. doi:10.1016/j.ccr.2004.06.010 PubMedCrossRef

45.

Scotton CJ, Wilson JL, Milliken D et al (2001) Epithelial cancer cell migration: a role for chemokine receptors. Cancer Res 61:4961–4965PubMed

46.

Sun YX, Wang J, Shelburne CE et al (2003) Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89:462–473. doi:10.1002/jcb.10522 PubMedCrossRef

47.

Li JK, Yu L, Shen Y et al (2008) Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol 14:2308–2313. doi:10.3748/wjg.14.2308 PubMedCrossRef

48.

Gilbert D, Chandler J, McIntyre A et al (2008) Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumors of adults and adolescents. J Pathol 217:94–102CrossRef

49.

Thomas RM, Kim J, Revelo-Penafield MP et al (2008) The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia. Gut 57:1555–1560. doi:10.1136/gut.2007.143941 PubMedCrossRef

50.

Suzuki M, Mohamed S, Nakajima T et al (2008) Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis. Int J Oncol 33:113–119PubMed

51.

Yoshitake N, Fukui H, Yamagishi H et al (2008) Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98:1682–1689. doi:10.1038/sj.bjc.6604363 PubMedCrossRef

52.

Blot E, Laberge-Le Couteulx S, Jamali H et al (2008) CXCR4 membrane expression in node-negative breast cancer. Breast J 14:268–274. doi:10.1111/j.1524-4741.2008.00573.x PubMedCrossRef

53.

Boldajipour B, Mahabaleshwar H, Kardash E (2008) Control of chemokine-guided cell migration by ligand sequestration. Cell 132:463–473. doi:10.1016/j.cell.2007.12.034 PubMedCrossRef

54.

Fujiwara H, Saga Y, Takahashi K et al (2008) Omental metastases in clinical stage I endometrioid adenocarcinoma. Int J Gynecol Cancer 18:165–167. doi:10.1111/j.1525-1438.2007.01101.x PubMedCrossRef

55.

Sohaib SA, Houghton SL, Meroni R et al (2007) Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 62:28–34. doi:10.1016/j.crad.2006.06.015 PubMedCrossRef

Title: The CXCR4/CXCL12 axis in endometrial cancer
Authors: Stefania Gelmini
Monica Mangoni
Francesca Castiglione
Cristina Beltrami
Annalisa Pieralli
Karin Louise Andersson
Massimiliano Fambrini
Gian Luigi Taddei
Mario Serio
Claudio Orlando
Publication date: 01-03-2009
Publisher: Springer Netherlands
Published in: Clinical & Experimental Metastasis / Issue 3/2009
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-009-9240-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications

Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells

BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter

Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity

Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature

Role of PKCβ in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target

Keynote webinar | Spotlight on antibody–drug conjugates in cancer